n(1)-isonicotinoyl-n(2)-3-methyl-4-chlorobenzoylhydrazine has been researched along with isoniazid in 6 studies
*Isoniazid: Antibacterial agent used primarily as a tuberculostatic. It remains the treatment of choice for tuberculosis. [MeSH]
*Isoniazid: Antibacterial agent used primarily as a tuberculostatic. It remains the treatment of choice for tuberculosis. [MeSH]
| Studies (n(1)-isonicotinoyl-n(2)-3-methyl-4-chlorobenzoylhydrazine) | Trials (n(1)-isonicotinoyl-n(2)-3-methyl-4-chlorobenzoylhydrazine) | Recent Studies (post-2010) (n(1)-isonicotinoyl-n(2)-3-methyl-4-chlorobenzoylhydrazine) | Studies (isoniazid) | Trials (isoniazid) | Recent Studies (post-2010) (isoniazid) |
|---|---|---|---|---|---|
| 6 | 0 | 0 | 21,815 | 960 | 4,493 |
| Protein | Taxonomy | n(1)-isonicotinoyl-n(2)-3-methyl-4-chlorobenzoylhydrazine (IC50) | isoniazid (IC50) |
|---|---|---|---|
| Myeloperoxidase | Homo sapiens (human) | 4.85 | |
| Enoyl-[acyl-carrier-protein] reductase [NADH] | Mycobacterium tuberculosis H37Rv | 8.29 | |
| Putative FAD-containing monooxygenase MymA | Mycobacterium tuberculosis H37Rv | 4.9 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (50.00) | 18.7374 |
| 1990's | 2 (33.33) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kristenson, K; Payne, LG | 1 |
| Gubser, J; Payne, LG; Schmutz, C; Wittek, R | 1 |
| Jockusch, BM; Jungwirth, C; Krempien, U | 1 |
| Eibl, H; Hiller, G; Weber, K | 1 |
| Cossart, P; Cudmore, S; Griffiths, G; Way, M | 1 |
| Boulanger, D; Skinner, MA; Smith, T | 1 |
6 other study(ies) available for n(1)-isonicotinoyl-n(2)-3-methyl-4-chlorobenzoylhydrazine and isoniazid
| Article | Year |
|---|---|
Mechanism of vaccinia virus release and its specific inhibition by N1-isonicotinoyl-N2-3-methyl-4-chlorobenzoylhydrazine.
Topics: Animals; Cell Line; Cell Membrane; Isoniazid; Rabbits; Vaccinia virus | 1979 |
A mutation in the gene encoding the vaccinia virus 37,000-M(r) protein confers resistance to an inhibitor of virus envelopment and release.
Topics: Amino Acid Sequence; Animals; Base Sequence; Cells, Cultured; Drug Resistance, Microbial; Genes, Viral; In Vitro Techniques; Isoniazid; Molecular Sequence Data; Molecular Weight; Mutation; Rabbits; Restriction Mapping; Vaccinia virus; Viral Envelope Proteins; Viral Plaque Assay; Viral Structural Proteins; Virus Replication | 1991 |
Herpes simplex virus-induced cell surface protrusions.
Topics: Animals; Cells, Cultured; Chick Embryo; Cytoskeletal Proteins; Herpes Simplex; Isoniazid; Microscopy, Electron, Scanning; Microvilli; Virus Replication | 1984 |
Characterization of intracellular and extracellular vaccinia virus variants: N1-isonicotinoyl-N2-3-methyl-4-chlorobenzoylhydrazine interferes with cytoplasmic virus dissemination and release.
Topics: Animals; Cell Membrane; Cells, Cultured; Centrifugation, Density Gradient; Chick Embryo; Isoniazid; Microvilli; Phospholipids; Rabbits; Vaccinia virus; Viral Proteins | 1981 |
Actin-based motility of vaccinia virus.
Topics: Actins; Cell Membrane; Cytoskeleton; HeLa Cells; Humans; Isoniazid; Microscopy, Video; Microvilli; Movement; Vaccinia virus | 1995 |
Morphogenesis and release of fowlpox virus.
Topics: Actins; Amino Acid Sequence; Animals; Brefeldin A; Cell Membrane; Cells, Cultured; Chick Embryo; Cytochalasin D; Fowlpox virus; Glucosamine; Isoniazid; Membrane Fusion; Microscopy, Electron; Molecular Sequence Data; Monensin; Mutation; Sequence Homology, Amino Acid; Species Specificity; Vaccinia virus; Viral Proteins; Virus Replication | 2000 |